Phase 3 Readout~month
Phase 3 Topline: A Phase 3 Study of Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects
- Company
- Organon & Co. (OGN)
- Drug
- tapinarof
- Indication
- Plaque Psoriasis
Other upcoming events for OGN
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.